| Tag | Content |
|---|
EnhancerAtlas ID | HS007-00591 |
Organism | Homo sapiens |
Tissue/cell | BE2C |
Coordinate | chr1:71484100-71486120 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Lhx3 | MA0135.1 | chr1:71485484-71485497 | GAAAAATTAATTT | - | 6.11 | | Lhx3 | MA0135.1 | chr1:71484859-71484872 | GAATTAATTATTC | + | 6.46 | | Myog | MA0500.1 | chr1:71485062-71485073 | CTGCAGCTGTT | - | 6.02 | | RELA | MA0107.1 | chr1:71485679-71485689 | GGAAATTCCC | - | 6.02 | | Tcf12 | MA0521.1 | chr1:71485062-71485073 | CTGCAGCTGTT | - | 6.62 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_00652 | chr1:71482169-71489315 | Adipose_Nuclei |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr1 | 71484534 | 71485379 | | chr1 | 71485434 | 71485781 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I071016 | chr1 | 71482170 | 71489315 |
|
Enhancer Sequence | GTTATAAAAT TAATATTTTC AACTCAGTTG GCTTTATGAA AAAAAGCTTA TTAATCCCTT 60
TCCCCTCTTT TTATAAACTA TTAGAAAAGT TTTGCTTATC TTTTTCAGTC CTTTACCCCA 120
CCCAATAGTT AAATATATTT GACCACTTAC TATCCTCCAG AAAGTGTTCT GGGCCTCGTC 180
TAGAATTATC TAAAAACTCA CTTAAATTAT GTTTTTATTT TCTCTATAAA ATAAAGAATT 240
GGATTTCTCT AACTTTTTGT GATCAGGAAA ATTCACAAAA TTACTTATTA AAATGATACG 300
TCAGTCATTT TACACAGTCC TCCTTGATTA TTTGAAAATT AATTTTTGTG AGGCTAATAA 360
TTTAAAATTA TTGTTATGAG GCAAATATAG GTTTCATATG CCTTACATTG TTTAGTACAC 420
TGTAATTTCC TATTGAGAAT GCAATGATTC TGAAATTATA AAATCAGCCA GTAGCTGGCA 480
CATGAGGAGA GACATTAGCT TTCCCCAGAA ATCATGAGAT GTGCAATATA GAGATAATTG 540
GAATTAGAAG CAGTGAGCAT GCTACTGCCA TTTCCAAATG GCAGCAGAGA TGAAACTGGG 600
GCTCCAAATT CTTCATCCAA TTTTGAACAT AAATTCAAAT TAGCATCCAT CTGTTGAGTC 660
TTTATATTTA AGCCATAATT ATAATTTCTG TGTATGTGTT TGCAAATATC TTTCAGACTG 720
TTTAGACTTT GAGAGAAAAC CTTAGGCATG AATATGGTAG AATTAATTAT TCCTATTAGT 780
CCAATTCTGT GTCATACAAG GGAGAGGGAC CAAAGAAAAA GCAGGATGCT CAGCTAACAG 840
AGAGGCTGTT TACTGGTTTT AGCAAACACA CATATACCCT GCACTATTTC TCCTTTCAAA 900
CAGCCTCATA TAACAAATGA TCTGGTCAAG GGAGTCGTGA GACCAATTCT AGCTGAACGG 960
AGCTGCAGCT GTTCTGTCAG CCCCTTCCCT GGGTTCCACG TGACTCTCCC AGGCCCTCTA 1020
GCAGAGCTCT CCCTTGGTTA TCAGCAGTAA TAGAGAGCTT CTTTATGCAC TTGAGATAAC 1080
TGGGAACACA ACTACATCAG TGACCTCTAA ATTCGCCATC CCTGTCTACT GTCAAGTACA 1140
ATTACCTTGT TCCATCCTAA AGGAAAAAAA TGATTTACCC TTTCCCCAGT GATAACGTTC 1200
TTTTAAGTGT TCAAAGCATT AATCAGGGAG GCTGTCTTTA ATATTCTATC CTTGGATTTT 1260
ATTCTATTGC AGCAGGATTT ATAATCACAC ACTTAAAAAT CTTTAGTACT TCACTTCTTA 1320
ATTTAAAAAT GCCTTGGGTT GTAGGCCACA CATATCTATT AAAGATGATA AATGAGGAAA 1380
CCCAGAAAAA TTAATTTATG GGGGAGGAAA TAAATTGGTT AGCTGCCCTT AGGCTCAATT 1440
CTGGGGTGTT TCTGCATTTC CAGTTTATTC CTAATGCAAG TGTTTAAGAG AAGTTTCCTC 1500
ACAAGCCAAT TTTTATCTGC GATGTTTTGT TTTCCGTAAT TCTCTGTTGT TAGGTTATGG 1560
GAGAATAACC TGCTCTACTG GAAATTCCCC CCTATAATTT GATAAGTGTA TTTCATCATA 1620
ATACACTAAA ACCAGTCTGG GCCCTTTAAA CTAGTTAATT ATGTAATTTG AAGGATTTGC 1680
ATGGGAAGAA GCTTCACTGT GGATTAAGAA ACAATTGTAG TCTCTCCAAT CTGGTTACAA 1740
CAGTTCTCCA GTTGTCAAAT CATCTCTGGA TCCTAGACTA CTGTTTCAAA AGCTTTCCCT 1800
GCCTTATTTA AACTGAAAAC ATTACAAATA AACAGCTCAT AAACATTAAA AAAATTAGTA 1860
GAATTTGTGC CATTTCGTCA TTACTACTAC GTAATTTTAT AAGATTTTTT AAAACAACAA 1920
TGGATTAAGA ATCAAGTAAA TTATATTGCT AGTTTTGCCA TCATTTACAA CTTTAGAAAA 1980
GTCATTTATC TCTGAACTTT ATTAAATTTA TTAGTAAGCA 2020
|
